- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Aegerion Pharmaceuticals Inc
+ Add to WatchlistAEGR:US
60.0900 USD 0.8700 1.43%As of 20:10:00 ET on 05/24/2013.
Company Profile for Aegerion Pharmaceuticals Inc (AEGR)
Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company researches small-molecule therapeutics for cardiovascular and metabolic desease. Aegerion's product candidates limit secretion of cholesterol and triglycerides.
Contact Information
Aegerion Pharmaceuticals Inc
101 Main Street
Suite 1850
Cambridge, MA 02142
United States
Key Executives for Aegerion Pharmaceuticals Inc (AEGR)
| Marc C BeerChief Executive Officer | Mark J FitzpatrickChief Financial Officer |
| Mark SumerayChief Medical Officer | Martha J CarterChief Regulatory Officer |
| Craig FraserPresident: US Commercial | Anne Marie CookSenior VP/Secretary/Gen Cnsl |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page